The real-world cost-effectiveness of adjuvant trastuzumab in HER-2/neu-positive early breast cancer in Taiwan

Hui Chu Lang, Hsiao Wei Chen, Tzeon Jye Chiou, Agnes L.F. Chan

研究成果: 雜誌貢獻 › 文章 › 同行評審

24 引文 斯高帕斯（Scopus）

指紋

深入研究「The real-world cost-effectiveness of adjuvant trastuzumab in HER-2/neu-positive early breast cancer in Taiwan」主題。共同形成了獨特的指紋。

Medicine & Life Sciences

Social Sciences